 This is an investigational study. Nivolumab is FDA-approved and commercially available for the treatment of certain kinds of melanoma. Nivolumab is not FDA approved or commercially available for the treatment of MF. It is currently being used for research purposes only. The study doctor can explain how the study drug is designed to work. 